As group health insurance premiums and hospitalization claims rise across Indian workplaces, corporates are turning to genetic screening as a preventive strategy — one that can reduce employee hospitalization costs by up to 30%. Indus Health Plus, a genomics and preventive healthcare company, is calling on HR heads, CHROs, and CFOs to rebuild wellness budgets around early disease prediction rather than after-the-fact treatment.

The Cost of Reactive Healthcare

Lifestyle diseases — diabetes, cardiovascular conditions, cancers — drive most corporate hospitalization claims in India. Standard health check-ups catch these only after symptoms appear, when treatment costs and absenteeism have already escalated. Genetic screening flags inherited disease risk years in advance, enabling early intervention before costs spike.

"Corporate India is at an inflection point where preventive genomics is a cost-control strategy, not a luxury benefit," said a spokesperson for Indus Health Plus. "Knowing an employee's genetic risk in advance is what turns reactive spending into preventive savings."

How the Savings Happen

Indus Health Plus's corporate offering, built around its MEDNAwise and DNAwise reports, targets three cost drivers:

Early Disease Prediction — flags risk before onset, avoiding costly emergency treatment.
Pharmacogenomics-Led Prescribing — MEDNAwise guides individualized drug response, cutting adverse reactions and repeat hospitalizations from trial-and-error prescribing.
Targeted Wellness Spend — directs budgets toward the workforce's actual risk profile instead of generic programs.
Built for HR and Insurance Workflows

The solution integrates directly into existing benefits structures with white-labeled, customizable reports, API integration for HR-tech and insurance platforms, genetic counselling support, HR training, and end-to-end technical support — backed by an in-house bioinformatics pipeline and strict data privacy protocols.

A Priority for CHROs and CFOs

With rising claim ratios pushing insurance premiums higher, genetic screening offers a rare alignment point: HR gets a differentiated wellness benefit, Finance gets a data-driven path to controlling long-term healthcare spend.

Take the Next Step

Organizations looking to reduce hospitalization costs and modernize employee wellness are invited to speak with the Indus Health Plus corporate team.

Book a call or partner with Indus Health Plus to explore genetic screening for your 2026 benefits strategy: https://www.indushealthplus.com/genetic-dna-testing/corporate-employers.html#